Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Current Leases (2016 - 2025)

Historic Current Leases for Ironwood Pharmaceuticals (IRWD) over the last 17 years, with Q3 2025 value amounting to $3.2 million.

  • Ironwood Pharmaceuticals' Current Leases rose 198.55% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year increase of 198.55%. This contributed to the annual value of $3.2 million for FY2024, which is 201.54% up from last year.
  • Per Ironwood Pharmaceuticals' latest filing, its Current Leases stood at $3.2 million for Q3 2025, which was up 198.55% from $3.2 million recorded in Q2 2025.
  • In the past 5 years, Ironwood Pharmaceuticals' Current Leases ranged from a high of $3.2 million in Q3 2025 and a low of $3.0 million during Q3 2022
  • For the 5-year period, Ironwood Pharmaceuticals' Current Leases averaged around $3.1 million, with its median value being $3.1 million (2024).
  • Its Current Leases has fluctuated over the past 5 years, first skyrocketed by 6759.06% in 2021, then plummeted by 338.93% in 2022.
  • Over the past 5 years, Ironwood Pharmaceuticals' Current Leases (Quarter) stood at $3.1 million in 2021, then decreased by 1.98% to $3.1 million in 2022, then grew by 1.99% to $3.1 million in 2023, then increased by 2.02% to $3.2 million in 2024, then grew by 1.47% to $3.2 million in 2025.
  • Its Current Leases stands at $3.2 million for Q3 2025, versus $3.2 million for Q2 2025 and $3.2 million for Q1 2025.